Published in J Clin Invest on January 01, 2001
Allergy Immunotherapy in the Management of Eosinophilic Esophagitis (AIMEE) | NCT01685034
Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest (2006) 5.48
Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis. J Allergy Clin Immunol (2012) 3.45
Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol (2009) 2.55
Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. Gut (2010) 2.31
Biology and treatment of eosinophilic esophagitis. Gastroenterology (2009) 2.18
Food allergy testing in eosinophilic esophagitis: what the gastroenterologist needs to know. Clin Gastroenterol Hepatol (2013) 2.17
Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels. J Allergy Clin Immunol (2008) 2.04
Seasonal variation in detection of oesophageal eosinophilia and eosinophilic oesophagitis. Aliment Pharmacol Ther (2015) 1.99
Involvement of mast cells in eosinophilic esophagitis. J Allergy Clin Immunol (2010) 1.92
Diagnosis and management of eosinophilic esophagitis. Clin Gastroenterol Hepatol (2012) 1.90
Predictors of response to steroid therapy for eosinophilic esophagitis and treatment of steroid-refractory patients. Clin Gastroenterol Hepatol (2014) 1.87
A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol (2011) 1.82
Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses. Mucosal Immunol (2008) 1.79
Eosinophil infiltration and degranulation in oesophageal mucosa from adult patients with eosinophilic oesophagitis: a retrospective and comparative study on pathological biopsy. J Clin Pathol (2006) 1.75
Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology (2007) 1.71
A review of eosinophilic gastroenteritis. J Natl Med Assoc (2006) 1.54
Rapidly increasing prevalence of eosinophilic oesophagitis in Western Australia. Arch Dis Child (2006) 1.53
Basic pathogenesis of eosinophilic esophagitis. Gastrointest Endosc Clin N Am (2008) 1.45
Eosinophilic esophagitis. Dig Dis Sci (2009) 1.43
Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis. Dig Dis Sci (2011) 1.43
IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway. J Immunol (2010) 1.41
High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders. J Allergy Clin Immunol (2013) 1.35
Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol (2014) 1.34
Anti-Siglec-F antibody inhibits oral egg allergen induced intestinal eosinophilic inflammation in a mouse model. Clin Immunol (2009) 1.31
Prevalence of esophageal eosinophilia varies by climate zone in the United States. Am J Gastroenterol (2012) 1.28
Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci (2009) 1.26
Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract. J Allergy Clin Immunol (2010) 1.25
Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis. Gastroenterology (2014) 1.23
Tissue remodeling in eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol (2012) 1.20
Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN-gamma (Mig, CXCL9). Proc Natl Acad Sci U S A (2004) 1.18
Role of Eotaxin-1 (CCL11) and CC chemokine receptor 3 (CCR3) in bleomycin-induced lung injury and fibrosis. Am J Pathol (2005) 1.18
Eosinophilic esophagitis: strictures, impactions, dysphagia. Dig Dis Sci (2003) 1.17
Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr (2011) 1.15
Eosinophilic gastroenteritis: an unusual type of gastroenteritis. World J Gastroenterol (2013) 1.13
The development of a sensitive and specific ELISA for mouse eosinophil peroxidase: assessment of eosinophil degranulation ex vivo and in models of human disease. J Immunol Methods (2011) 1.12
Molecular, genetic, and cellular bases for treating eosinophilic esophagitis. Gastroenterology (2015) 1.11
De-novo onset of eosinophilic esophagitis after large volume allergen exposures. J Gastrointestin Liver Dis (2013) 1.10
Eosinophilic esophagitis. World J Gastroenterol (2009) 1.09
Significance of para-esophageal lymph nodes in food or aeroallergen-induced iNKT cell-mediated experimental eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol (2011) 1.09
Esophageal functional impairments in experimental eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol (2012) 1.09
Allergy and eosinophil-associated gastrointestinal disorders (EGID). Curr Opin Immunol (2008) 1.09
Eosinophilic esophagitis: the newest esophageal inflammatory disease. Nat Rev Gastroenterol Hepatol (2009) 1.09
Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice. Gastroenterology (2010) 1.08
Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis. Dig Dis Sci (2006) 1.07
Serum IgE measurement and detection of food allergy in pediatric patients with eosinophilic esophagitis. Ann Allergy Asthma Immunol (2010) 1.05
An imbalance of esophageal effector and regulatory T cell subsets in experimental eosinophilic esophagitis in mice. Am J Physiol Gastrointest Liver Physiol (2009) 1.05
Esophageal eosinophilia is increased in rural areas with low population density: results from a national pathology database. Am J Gastroenterol (2014) 1.00
Clinical characteristics and sensitivity to food and inhalants among children with eosinophilic esophagitis. BMC Res Notes (2014) 0.98
Pathogenic role of mast cells in experimental eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol (2013) 0.98
IL-13 receptor α1 differentially regulates aeroallergen-induced lung responses. J Immunol (2011) 0.98
Eotaxin and FGF enhance signaling through an extracellular signal-related kinase (ERK)-dependent pathway in the pathogenesis of Eosinophilic esophagitis. Allergy Asthma Clin Immunol (2010) 0.97
Eosinophils in mucosal immune responses. Mucosal Immunol (2015) 0.97
Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis. J Allergy Clin Immunol (2014) 0.97
Indoor insect allergens are potent inducers of experimental eosinophilic esophagitis in mice. J Leukoc Biol (2010) 0.96
The link between allergies and eosinophilic esophagitis: implications for management strategies. Expert Rev Clin Immunol (2010) 0.95
Downregulation of glutathione S-transferase pi in asthma contributes to enhanced oxidative stress. J Allergy Clin Immunol (2011) 0.94
Role of acid and nonacid reflux in children with eosinophilic esophagitis compared with patients with gastroesophageal reflux and control patients. J Pediatr Gastroenterol Nutr (2008) 0.93
Mechanism of eosinophilic esophagitis. Immunol Allergy Clin North Am (2009) 0.93
Epicutaneous immunotherapy (EPIT) blocks the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized mice. PLoS One (2012) 0.92
Markers of tyrosine kinase activity in eosinophilic esophagitis: a pilot study of the FIP1L1-PDGFRα fusion gene, pERK 1/2, and pSTAT5. Dis Esophagus (2011) 0.91
Food allergy: recent advances in pathophysiology and treatment. Allergy Asthma Immunol Res (2009) 0.90
Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases. Clin Exp Allergy (2008) 0.89
Clinical analysis of primary eosinophilic esophagitis. J Neurogastroenterol Motil (2013) 0.89
Eosinophilic esophagitis: perspectives of adult and pediatric gastroenterologists. Dig Dis Sci (2009) 0.88
Pathogenesis of allergen-induced eosinophilic esophagitis is independent of interleukin (IL)-13. Immunol Cell Biol (2013) 0.88
Interleukin-13 directly promotes oesophagus production of CCL11 and CCL24 and the migration of eosinophils. Clin Exp Allergy (2009) 0.88
Eosinophilic gastroenteritis: review of a rare and treatable disease of the gastrointestinal tract. Case Rep Gastroenterol (2013) 0.87
Eosinophils in Gastrointestinal Disorders: Eosinophilic Gastrointestinal Diseases, Celiac Disease, Inflammatory Bowel Diseases, and Parasitic Infections. Immunol Allergy Clin North Am (2015) 0.87
Eosinophilic esophagitis investigated by upper gastrointestinal endoscopy in Japanese patients. J Gastroenterol (2011) 0.86
Recent advances in the treatment of eosinophilic esophagitis. Expert Rev Clin Immunol (2010) 0.85
Invariant natural killer T-cell neutralization is a possible novel therapy for human eosinophilic esophagitis. Clin Transl Immunology (2014) 0.85
Genetic and epigenetic underpinnings of eosinophilic esophagitis. Gastroenterol Clin North Am (2014) 0.84
Eosinophilic gastrointestinal diseases: review and update. ISRN Gastroenterol (2012) 0.84
Eosinophilic gastrointestinal diseases--clinically diverse and histopathologically confounding. Semin Immunopathol (2012) 0.84
Routine screening for eosinophilic esophagitis in patients presenting with dysphagia. Therap Adv Gastroenterol (2011) 0.84
Mepolizumab in eosinophilic disorders. Expert Rev Clin Immunol (2011) 0.83
Elevated levels of leukotriene C4 synthase mRNA distinguish a subpopulation of eosinophilic oesophagitis patients. Clin Exp Allergy (2013) 0.83
Skin prick testing does not reflect the presence of IgE against food allergens in adult eosinophilic esophagitis patients: a case study. Clin Mol Allergy (2010) 0.82
Management of refractory eosinophilic esophagitis. Dig Dis (2014) 0.82
Allergen-induced resistin-like molecule-α promotes esophageal epithelial cell hyperplasia in eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol (2014) 0.81
Involvement of interleukin-18 in the pathogenesis of human eosinophilic esophagitis. Clin Immunol (2015) 0.80
Treatments for food allergy: how close are we? Immunol Res (2012) 0.80
International survey on evaluation and management of eosinophilic esophagitis. World Allergy Organ J (2012) 0.80
Eosinophilic esophagitis: which role for food and inhalant allergens? Asia Pac Allergy (2012) 0.80
Upregulated eotaxin expression and T cell infiltration in the basal and papillary epithelium in cows' milk associated reflux oesophagitis. Arch Dis Child (2002) 0.79
Correlation between Aeroallergen Levels and New Diagnosis of Eosinophilic Esophagitis in NYC. J Pediatr Gastroenterol Nutr (2016) 0.79
Allergic mechanisms of Eosinophilic oesophagitis. Best Pract Res Clin Gastroenterol (2015) 0.79
Diagnostic and therapeutic strategies for eosinophilic esophagitis. Clin Pract (Lond) (2014) 0.78
An allergist's perspective to the evaluation of Eosinophilic Esophagitis. Best Pract Res Clin Gastroenterol (2015) 0.77
The Immunologic Mechanisms of Eosinophilic Esophagitis. Curr Allergy Asthma Rep (2016) 0.77
The pathophysiology of eosinophilic esophagitis. Front Pediatr (2014) 0.77
Eosinophilic oesophagitis: clinical presentation and pathogenesis. Postgrad Med J (2014) 0.77
Expanding the paradigm of eosinophilic esophagitis: mast cells and IL-9. J Allergy Clin Immunol (2013) 0.77
Eosinophilic esophagitis: published evidences for disease subtypes, indications for patient subpopulations, and how to translate patient observations to murine experimental models. World Allergy Organ J (2016) 0.76
Proton pump inhibitor responsive esophageal eosinophilia, a distinct disease entity? World J Gastroenterol (2014) 0.76
Significance of Mouse Models in Dissecting the Mechanism of Human Eosinophilic Gastrointestinal Diseases (EGID). J Gastroenterol Hepatol Res (2015) 0.76
Eosinophilic esophagitis: New insights in pathogenesis and therapy. World J Gastrointest Pharmacol Ther (2016) 0.76
The Role of Environmental Exposures in the Etiology of Eosinophilic Esophagitis: A Systematic Review. Mayo Clin Proc (2015) 0.76
Allergen-induced interleukin-18 promotes experimental eosinophilic oesophagitis in mice. Immunol Cell Biol (2015) 0.76
Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med (1996) 6.34
Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol (1999) 5.51
The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent. J Immunol (1988) 4.38
Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology (1995) 4.24
Eosinophilia. N Engl J Med (1998) 4.14
Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr (1998) 2.87
Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med (1995) 2.83
Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med (1997) 2.68
Food allergy. Part 1: immunopathogenesis and clinical disorders. J Allergy Clin Immunol (1999) 2.46
The epidemic of allergy and asthma. Nature (1999) 2.42
The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children. Am J Gastroenterol (2000) 2.10
Eosinophilic gastroenteritis. J Pediatr Gastroenterol Nutr (2000) 2.07
Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest (1999) 2.05
Eotaxin is required for the baseline level of tissue eosinophils. Proc Natl Acad Sci U S A (1998) 1.98
Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. J Allergy Clin Immunol (1992) 1.95
Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol (1997) 1.79
Molecular and biological characterization of the murine leukotriene B4 receptor expressed on eosinophils. J Exp Med (1998) 1.75
Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology (1982) 1.73
Allergic esophagitis in children: a clinicopathological entity. Am J Surg Pathol (1999) 1.53
Severity of esophageal eosinophilia predicts response to conventional gastroesophageal reflux therapy. Pediatr Dev Pathol (1999) 1.43
Antigen-induced eosinophilic lung inflammation develops in mice deficient in chemokine eotaxin. Blood (1998) 1.33
Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways. Am J Respir Crit Care Med (1999) 1.31
Chemokines and allergic disease. J Allergy Clin Immunol (1999) 1.20
Chemokines and asthma: redundancy of function or a coordinated effort? J Clin Invest (1999) 1.16
Gastroesophageal reflux and asthma: insight into the association. J Allergy Clin Immunol (1999) 1.13
Summary and recommendations: Classification of gastrointestinal manifestations due to immunologic reactions to foods in infants and young children. J Pediatr Gastroenterol Nutr (2000) 1.12
Human eosinophils in vitro. An ultrastructural morphology primer. Histol Histopathol (1994) 1.07
The ABA-1 allergen of Ascaris lumbricoides: sequence polymorphism, stage and tissue-specific expression, lipid binding function, and protein biophysical properties. Parasitology (2000) 1.04
Eosinophils in the esophagus: acid is not the only cause. J Pediatr Gastroenterol Nutr (1998) 1.00
Criteria of eosinophilia. Lancet (1946) 0.97
Purification of Ascaris suum antigen: its allergenic activity in vitro and in vivo. J Allergy Clin Immunol (1986) 0.93
Bromo-deoxyuridine (BRDU) uptake in the lungs of rats inhaling amosite asbestos or vitreous fibres at equal airborne fibre concentrations. Exp Toxicol Pathol (1995) 0.91
Effect of Ascaris suum and other adjuvants on the potentiation of the IgE response in guinea-pigs. Immunology (1979) 0.87
Late pulmonary responses induced by Ascaris allergen in conscious squirrel monkeys. J Appl Physiol (1985) (1986) 0.83
The spectrum of food hypersensitivity: where does it end? J Pediatr (1998) 0.83
Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med (1996) 6.34
Postnatal mammary gland development requires macrophages and eosinophils. Development (2000) 3.10
Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J Exp Med (1987) 2.69
Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med (1996) 2.55
Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. Gut (2010) 2.31
Distinct roles for IL-13 and IL-4 via IL-13 receptor alpha1 and the type II IL-4 receptor in asthma pathogenesis. Proc Natl Acad Sci U S A (2008) 2.06
Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest (1999) 2.05
Eotaxin is required for the baseline level of tissue eosinophils. Proc Natl Acad Sci U S A (1998) 1.98
Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med (1989) 1.97
Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses. Mucosal Immunol (2008) 1.79
Molecular and biological characterization of the murine leukotriene B4 receptor expressed on eosinophils. J Exp Med (1998) 1.75
IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. J Allergy Clin Immunol (2001) 1.74
Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils. Allergy (2008) 1.70
Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J Clin Invest (1997) 1.69
A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nat Immunol (2001) 1.58
Gastrointestinal eosinophils. Immunol Rev (2001) 1.57
Pathogenesis and clinical features of eosinophilic esophagitis. J Allergy Clin Immunol (2001) 1.50
Elemental signals regulating eosinophil accumulation in the lung. Immunol Rev (2001) 1.45
Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and eotaxin. Am J Respir Cell Mol Biol (2001) 1.41
Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J Immunol (2000) 1.39
Identification of a mouse eosinophil receptor for the CC chemokine eotaxin. Biochem Biophys Res Commun (1996) 1.36
Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354). Clin Exp Allergy (2005) 1.26
Molecular characterization of two murine eosinophil beta chemokine receptors. J Immunol (1995) 1.26
Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity. Clin Exp Allergy (2006) 1.24
The effect of IL-5 and eotaxin expression in the lung on eosinophil trafficking and degranulation and the induction of bronchial hyperreactivity. J Immunol (2000) 1.20
Interleukin-5-mediated allergic airway inflammation inhibits the human surfactant protein C promoter in transgenic mice. J Biol Chem (2000) 1.19
Inhibition of allergic airway inflammation in mice lacking nitric oxide synthase 2. J Immunol (1999) 1.17
Eosinophils cocultured with endothelial cells have increased survival and functional properties. Science (1987) 1.16
A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy. Proc Natl Acad Sci U S A (2000) 1.14
The R576 IL-4 receptor alpha allele correlates with asthma severity. J Allergy Clin Immunol (1999) 1.12
Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation. J Leukoc Biol (1997) 1.12
CC chemokine receptor-3 undergoes prolonged ligand-induced internalization. J Biol Chem (1999) 1.05
Regulation of intestinal barrier function by signal transducer and activator of transcription 5b. Gut (2008) 0.99
Quality of life in paediatric eosinophilic oesophagitis: what is important to patients? Child Care Health Dev (2011) 0.98
Genomic organization, complete sequence, and chromosomal location of the gene for human eotaxin (SCYA11), an eosinophil-specific CC chemokine. Genomics (1997) 0.98
Gastrointestinal eosinophils in health and disease. Adv Immunol (2001) 0.97
Chemokines and chemokine receptors: their role in allergic airway disease. J Clin Immunol (1999) 0.95
Eosinophil levels in mice are significantly higher in small blood vessels than in large blood vessels. J Allergy Clin Immunol (2001) 0.91
A murine model of allergic rhinitis: studies on the role of IgE in pathogenesis and analysis of the eosinophil influx elicited by allergen and eotaxin. J Allergy Clin Immunol (1998) 0.91
A plant-based allergy vaccine suppresses experimental asthma via an IFN-gamma and CD4+CD45RBlow T cell-dependent mechanism. J Immunol (2003) 0.90
MiR-375 is downregulated in epithelial cells after IL-13 stimulation and regulates an IL-13-induced epithelial transcriptome. Mucosal Immunol (2012) 0.90
Diesel exhaust particle exposure increases severity of allergic asthma in young mice. Clin Exp Allergy (2013) 0.89
Cellular and molecular regulation of eosinophil trafficking to the lung. Immunol Cell Biol (1998) 0.89
Hypereosinophilic syndromes. Chem Immunol (2000) 0.89
The alpha4bbeta7-integrin is dynamically expressed on murine eosinophils and involved in eosinophil trafficking to the intestine. Clin Exp Allergy (2006) 0.87
Molecular analysis of CCR-3 events in eosinophilic cells. J Immunol (2000) 0.86
A morphometric study of normodense and hypodense human eosinophils that are derived in vivo and in vitro. Am J Pathol (1990) 0.86
Building a better mouse model: experimental models of chronic asthma. Clin Exp Allergy (2005) 0.86
Review article: The eosinophil as a therapeutic target in gastrointestinal disease. Aliment Pharmacol Ther (2004) 0.85
Peyer's patch eosinophils: identification, characterization, and regulation by mucosal allergen exposure, interleukin-5, and eotaxin. Blood (2000) 0.84
FVB/N mice are highly resistant to primary infection with Nippostrongylus brasiliensis. Parasitology (2009) 0.83
The effects of the Nd:YAG laser on amalgam dental restorative material. Aust Dent J (1999) 0.83
Tryptase 4, a new member of the chromosome 17 family of mouse serine proteases. J Biol Chem (2001) 0.83
Polymorphisms in the human CC chemokine receptor-3 gene. Biochim Biophys Acta (1998) 0.80
Biochemical and morphological characterization of basophilic leukocytes from two patients with myelogenous leukemia. J Immunol (1987) 0.80
Chinese herbal anti-asthma tea to go! Clin Exp Allergy (2010) 0.80
Exclusion of defects in the skeletal muscle specific regions of the DHPR alpha 1 subunit as frequent causes of malignant hyperthermia. J Med Genet (1995) 0.78
Dietary allergenic proteins and intestinal immunity: a shift from oral tolerance to sensitization. Clin Exp Allergy (2007) 0.77
Epithelial cells are a major cellular source of the chemokine eotaxin in the guinea pig lung. Allergy Asthma Proc (1998) 0.76
Interleukin-4 and interleukin-5 as targets for the inhibition of eosinophilic inflammation and allergic airways hyperreactivity. Mem Inst Oswaldo Cruz (1997) 0.76
The metabolism of D-myo-inositol 1,4,5-trisphosphate and D-myo-inositol 1,3,4,5-tetrakisphosphate by porcine skeletal muscle. Eur J Biochem (1994) 0.76
Purification and characterization of D-myo-inositol (1,4,5)/(1,3,4,5)- polyphosphate 5-phosphatase from skeletal muscle. Arch Biochem Biophys (1994) 0.76
Neonatal Fc receptor (FcRn) and maternal-to-newborn IgE absorption. Clin Exp Allergy (2012) 0.75
Isolation of immunoreactive beta-endorphin-related and Met-enkephalin-related peptides from the posterior pituitary of the amphibian, Xenopus laevis. Peptides (1988) 0.75
Distinct spatial requirement for eosinophil-induced airways hyperreactivity. Immunol Cell Biol (2001) 0.75
Isolation of alpha-melanotropin from the pars intermedia of the larval amphibian, Ambystoma tigrinum. Gen Comp Endocrinol (1987) 0.75
Correction: ERBIN deficiency links STAT3 and TGF-β pathway defects with atopy in humans. J Exp Med (2017) 0.75
Ontogeny of in vitro-differentiated mouse mast cells. Fed Proc (1987) 0.75